Skip to main content

Meatal Stenosis Revision After Feminizing Genital Surgery

Meatal stenosis is the most common urethral complication of feminizing vaginoplasty — incidence 4–40% across individual series, 5–16.3% in systematic reviews, with Dreher 2018 meta-analytic rate 14.4%.[1][2][3] Management follows a stepwise approach: office-based dilation or meatotomy for first-time uncomplicated stenosis → formal meatoplasty (Y-V, neovaginal advancement flap, vestibular flap) for recurrent cases → buccal mucosal graft (BMG) urethroplasty for refractory or lichen sclerosus–associated strictures.[2][4][5]

This is the dedicated management-pathway page. For the primary urethroplasty component, see Feminizing Urethroplasty. For the periurethral / periclitoral architecture that drives stenosis risk, see Feminizing Labiaplasty and Clitoroplasty.

Definitions and Anatomy​

Meatal stenosis = narrowing of the neourethral meatus (the surgically created opening in the vestibule between neoclitoris and introitus). Distinct from (though may coexist with) urethral stricture — narrowing of the urethral lumen proximal to the meatus.[2][6]

Postoperative anatomy: male urethra (~18–20 cm) shortened to ~3–4 cm by excising the pendulous segment; prostatic + membranous + bulbar urethra preserved; distal stump spatulated and sutured to vestibular skin. The external urethral sphincter at the membranous urethra is preserved, maintaining continence. The neomeatus is therefore a surgically created mucocutaneous junction between native urethral mucosa (transitional / columnar) and surrounding keratinised perineal / vestibular skin — inherently prone to circumferential scar contracture, analogous to meatal stenosis after hypospadias repair or circumcision.[7][2][8]

Incidence​

SeriesnRateNotes
Dreher 2018 meta-analysis[3]1,68414.4%Most common complication overall
Nassiri 2020 SR[2]3,4634–40%Wide range; 10 MtF studies
Blasdel 2024 review[1]Multiple SRs5–16.3%Mean across 8 SRs
Motiwala 2026 narrative review[9]Multiple5–10%Transfeminine
Fakin 2021 single vs two-stage[10]1250% (single) vs 14.5% (two-stage)Significant technique difference
Levy 2019 high-volume single surgeon[11]2400.4% reoperation—
Mañero 2023 cosmetic revisions[12]3549.38% of all cosmetic revisionsUrethral meatus revisions

The 4–40% range reflects heterogeneous definitions — some series count any patient requiring a single office dilation, others count only formal revision. The Blasdel 2024 "surgical complication blind spots" review highlights that surgeon-reported rates likely underestimate the true burden, as patient-reported voiding dysfunction is 2–3× higher than surgeon-reported.[1]

Pathophysiology​

Circumferential scar contracture​

Wound healing at the circumferential mucocutaneous suture line produces concentric scar contracture — the same mechanism that drives meatal stenosis after hypospadias repair and circumcision.[2][8]

Inadequate spatulation​

Insufficient distal-urethral spatulation creates a small meatal opening from the outset that predisposes to stenosis. Adequate spatulation converts the circular lumen to a wider elliptical opening.[2]

Distal-stump ischemia​

The distal urethral stump relies on the surrounding corpus spongiosum for blood supply. Penile-disassembly–related spongiosal devascularisation drives ischemic contracture.[2][6]

Periurethral tissue architecture​

Raigosa 2020 refinement series demonstrated that incorporating labia-minora + clitoral-hood creation reduced meatal stenosis from 15.5% to 1.5% (p = 0.003) — the strongest direct evidence that the tissue surrounding the neomeatus, not just the urethral shortening itself, drives long-term patency.[13] Cross-link to the Feminizing Labiaplasty page for the full dataset.

Residual corpus spongiosum​

Bulky periurethral spongiosal tissue causes fullness and contributes to both stenosis and misdirected stream; debulking of residual spongiosum is part of some revision techniques.[14][15]

Lichen sclerosus (LS)​

LS can affect the genital skin of transgender women and drives progressive fibrosis and stricture. In the Waterloos neovaginal-flap series, 1/5 patients had LS-associated urethral stricture requiring BMG augmentation in addition to the neovaginal flap.[5] Per AUA 2023 Urethral Stricture Disease Guideline Amendment, LS-related strictures should be reconstructed with oral mucosal grafts, not genital skin — very high long-term failure rates with genital skin in LS.[4]

Wound infection​

Dreher meta-analysis: wound infection associated with increased risk of all tissue-healing complications.[3]

Clinical Presentation​

SymptomMechanism
Weak / diminished streamMost common presentation
StrainingCompensatory effort
HesitancyDelayed initiation
Spraying / misdirectedNarrowed irregular meatal opening
Incomplete emptyingElevated PVR
Frequency / urgencySecondary to incomplete emptying
Recurrent UTIUrinary stasis
RetentionSevere cases
DysuriaPain with voiding

Workup:[4][15]

  • History — onset, progression, relationship to primary-surgery timing, prior interventions.
  • Direct visualisation of the neomeatus — caliber, position, surrounding-tissue quality, LS features.
  • Uroflowmetry — Qmax < 12 mL/s is suggestive of obstruction.
  • Calibration with bougie-à-boules or paediatric sounds.
  • Cystoscopy when stricture extends beyond the meatus.
  • Post-void residual via bladder scan / catheterisation.
  • Biopsy if LS suspected — male LS carries a 2–8.6% SCC rate.[4]

Stepwise Management​

Step 1 — Office-based dilation​

For first-time uncomplicated stenosis without prior failed endoscopic manipulation, prior urethroplasty, or LS:[4]

  • Topical lidocaine; progressive urethral sounds / dilators.
  • High recurrence rate — pooled success only 49% for female urethral stricture vs > 85% for surgical reconstruction.[16]
  • Per AUA 2023, dilation or meatotomy is acceptable first-line for uncomplicated meatal stricture.[4]

Step 2 — Meatotomy​

Standard first-line surgical intervention:[2][4][17]

  • Dorsal meatotomy — simple incision through the dorsal aspect of the stenotic meatus to widen the opening; most commonly performed.[2]
  • Local anaesthesia (office) or sedation.
  • Success up to 87% in general urethral stricture populations.[4][18]
  • Large paediatric meatotomy series (n = 1,906): 0.58% reoperation rate; 3.6% required manual meatal spreading at first postoperative visit.[17]
  • AUA: extended meatotomy + high-dose topical steroids may reduce recurrence vs meatotomy alone, particularly in LS.[4]
  • Nassiri SR: meatal stenosis after MtF surgery usually requires meatotomy for repair.[2]

Step 3 — Formal Meatoplasty (recurrent stenosis)​

Per AUA 2023: offer urethroplasty to patients with recurrent meatal or fossa-navicularis strictures (Moderate Recommendation; Evidence Level C).[4]

A. Y-V meatoplasty (Sennert 2025) — small inverted-V skin flap (3–5 mm limbs) elevated at meatal tip; wedge of narrow meatus excised; V tip advanced distally. n = 57 (primarily post-hypospadias): 96.5% success, 3.5% recurrence at median 4-yr follow-up.[8]

B. Neovaginal advancement flap (Waterloos / Ghent) — the only published technique specifically designed for transgender women — n = 5; 100% success; no recurrence at median 37 mo (range 6–97):[5]

  • 7-flap (2 patients): flap shaped like the number 7, raised from the anterior neovaginal wall adjacent to the meatus.
  • Inverted U-flap (3 patients): U-shaped anterior-neovaginal flap rotated to augment the ventral urethral wall.
  • 1 LS patient: urethra additionally enlarged with buccal mucosa in addition to the neovaginal flap.
  • Median stricture length 2.0 cm; median OR time 41 min; all satisfied; 1 low-grade complication (bladder spasms).
  • The neovaginal wall (penile / scrotal skin) is the analogous tissue source to the native vaginal wall used in cisgender female urethral reconstruction — well-vascularised, pliable, adjacent.

C. Jordan flap (ventral preputial flap) — originally for cisgender male distal urethral strictures; uses a ventral preputial flap. n = 21, 100% success, no recurrence at mean 35 mo. Applicable in transgender patients with residual preputial tissue (used for clitoral hood).[19]

D. Vestibular flap meatoplasty (Romman 2015 cisgender analogue) — broad-based vestibular flap raised from labia minora adjacent to the meatus; stenotic distal-urethral wedge excised; flap rotated inward to bridge the defect, converting the obstructing O-shape to a C-shape. Vascularised flap prevents cut edges from scarring back together; no de novo SUI reported.[20]

Step 4 — Urethroplasty with Tissue Augmentation (refractory / extensive / LS)​

A. Buccal mucosal graft (BMG) urethroplasty — gold standard for recurrent meatal / fossa-navicularis strictures and LS:[4][21][22]

  • Harvested from inner cheek; dorsal onlay or ventral inlay augmentation.
  • Pooled success 56–100%; 69% at median 42 mo in the largest single-centre series (n = 32).[22]
  • Dorsal-onlay BMG (DOBMGU) — 87.5% success (7/8) at median 12 mo vs 57.1% for vaginal-flap urethroplasty in a recent comparative study.[21]
  • AUA 2023: LS-related strictures more likely to be reconstructed successfully with oral mucosal grafts; genital skin flaps / grafts should be avoided in LS due to very high long-term failure rates.[4]
  • In the transgender context, Waterloos used BMG as an adjunct to neovaginal flap in 1 LS patient with successful outcome.[5]

B. Vaginal / neovaginal flap urethroplasty — anterior neovaginal wall (penile / scrotal skin) as pedicled flap; Romero-Maroto / Orandi lateral-based anterior vaginal wall flap = 100% success in 9 cisgender patients at mean 80.7 mo, no recurrence, no de novo SUI. In the transgender context, the Waterloos technique is the published adaptation.[5][23]

Comparison of Revision Techniques​

TechniqueSuccessBest indication
Office dilation~49% (pooled)First-time mild stenosis[16]
Dorsal meatotomyup to 87%First-time uncomplicated stenosis[2][4]
Y-V meatoplasty96.5% (n = 57)Recurrent ring stenosis[8]
Neovaginal advancement flap (7 / U)100% (5/5, 37 mo)Distal urethral stricture in transwomen — only GAS-specific technique[5]
Vestibular flapHigh (small series)Recurrent distal stenosis[20]
BMG urethroplasty69–87.5%Recurrent / LS-associated stricture[21][22]
Jordan flap100% (n = 21)Distal stricture with available preputial tissue[19]

Concurrent Urethral Complaints​

Meatal stenosis frequently coexists with other urethral complaints. NYU vulvar revision series (Dy 2022): urologic complaints in 48.6% (17/35) of revision patients — third most common revision category after labial (77.1%) and clitoral (57.1%).[15]

Concurrent issueFrequencyMechanism / Management
Misdirected stream33–55% patient-reported[1]Meatal position, periurethral architecture, residual spongiosum
SprayingCommonMeatal shape; periurethral tissue
Periurethral fullness—Residual corpus spongiosum; may require debulking
Urethral diverticulumRarePost-void dribbling
Urethrovaginal fistulaRareContinuous urinary leakage from neovagina

These are often addressed concurrently in a single revision procedure that may also include labial, clitoral, and introital revisions.[15][24]

Lichen Sclerosus — Special Considerations​

LS deserves special attention in the transgender context:[4][5][25]

  • Affects genital skin of transgender women — penile / scrotal-skin canal lining and periurethral tissue.
  • Progressive fibrosis → meatal stenosis and urethral stricture.
  • Genital skin flaps / grafts should be avoided for reconstruction — remain prone to LS recurrence.[4]
  • BMG is the graft of choice for LS-associated strictures (oral mucosa is resistant to LS).[4][25]
  • Biopsy for definitive diagnosis — male LS carries 2–8.6% SCC rate.[4]
  • Topical clobetasol is the medical-therapy mainstay; may prevent progression to extensive stricture.[4][25]
  • Long-term surveillance for SCC.[4]

Prevention at Primary Surgery​

Strategies to reduce meatal stenosis:[3][10][13]

  • Adequate ventral spatulation of the distal urethra.
  • Periurethral tissue architecture — Raigosa 2020 labia-minora + clitoral-hood creation reduced meatal stenosis 15.5% → 1.5% (p = 0.003).[13]
  • Tension-free meatal suture line.
  • Foley 14–16 Fr for 5–14 d postoperatively.
  • Single-stage technique — Fakin 2021: 0% meatal stenosis single-stage vs 14.5% two-stage.[10]
  • Wound-infection prevention (Dreher meta-analysis association).[3]

Postoperative Management After Meatal Revision​

  • Foley 14–16 Fr through the revised meatus for 5–14 d to maintain patency during healing.
  • Topical estrogen or steroid cream (institution-dependent) to promote healing and reduce scar contracture.
  • Follow-up uroflowmetry at 4–6 wk for objective flow-rate assessment.
  • Periodic surveillance of meatal caliber and voiding symptoms — recurrence can occur months to years out.
  • Intermittent self-dilation sometimes recommended after meatoplasty (analogous to neovaginal dilation).
  • LS screening — biopsy + topical steroids if suspected; long-term dermatologic surveillance.[4]

Voiding Dysfunction Beyond Meatal Stenosis​

The Blasdel 2024 "blind spots" review quantifies the broader gap:[1]

Voiding parameterSurgeon-reportedPatient-reported
Voiding dysfunction5.6–33%47–66%
Misdirected stream9.5–33%33–55%
Urinary incontinence4–19.3%23–33%
Meatal stenosis5–16.3%Higher; not well characterised

Pelvic-floor PT is recommended pre- and post-operatively — pelvic-floor dysfunction affects up to 94.1% of transgender individuals after genital surgery; PFPT significantly reduces dysfunction rates.[9] See Neovaginal Stenosis Management for the broader PFPT framework (Jiang OHSU pre + post 28% vs 86%, FLOWER RCT no-routine-benefit signal).

Evidence Limitations​

  • No dedicated studies focus on meatal-stenosis revision after feminizing vaginoplasty — the Waterloos neovaginal-flap series (n = 5) is the only published technique specifically designed for this population.[5]
  • Heterogeneous definitions — "meatal stenosis" variably defined; wide reported range (4–40%).[2]
  • Surgeon-reported rates underestimate the true burden by 2–3×.[1]
  • No validated PROMs for urinary function in transgender women.[1][9]
  • No comparative trials between revision techniques (meatotomy vs meatoplasty vs BMG) in the transgender context.
  • LS prevalence in transgender women is unknown; no systematic evaluation of LS as a stenosis driver in this population.
  • Long-term outcomes of meatal revision beyond 3–5 yr poorly characterised.
  • Most management principles are extrapolated from cisgender male and female urethral-reconstruction literature with limited transgender-specific validation.[4][26]

References​

1. Blasdel G, Dy GW, Nikolavsky D, et al. Urinary reconstruction in genital gender-affirming surgery: checking our surgical complication blind spots. Plast Reconstr Surg. 2024;153(4):792e–803e. doi:10.1097/PRS.0000000000010813

2. Nassiri N, Maas M, Basin M, Cacciamani GE, Doumanian LR. Urethral complications after gender reassignment surgery: a systematic review. Int J Impot Res. 2020;33(8):793–800. doi:10.1038/s41443-020-0304-y

3. Dreher PC, Edwards D, Hager S, et al. Complications of the neovagina in male-to-female transgender surgery: a systematic review and meta-analysis with discussion of management. Clin Anat. 2018;31(2):191–199. doi:10.1002/ca.23001

4. Wessells H, Morey A, Souter L, Rahimi L, Vanni A. Urethral Stricture Disease Guideline Amendment (2023). J Urol. 2023;210(1):64–71. doi:10.1097/JU.0000000000003482

5. Waterloos M, Hollebosch S, Verla W, et al. Neo-vaginal advancement flaps in the treatment of urethral strictures in transwomen. Urology. 2019;129:217–222. doi:10.1016/j.urology.2019.02.003

6. Morrison SD, Claes K, Morris MP, et al. Principles and outcomes of gender-affirming vaginoplasty. Nat Rev Urol. 2023;20(5):308–322. doi:10.1038/s41585-022-00705-y

7. Saylor L, Bernard S, Vinaja X, Loukas M, Schober J. Anatomy of genital reaffirmation surgery (male-to-female): vaginoplasty using penile skin graft with scrotal flaps. Clin Anat. 2018;31(2):140–144. doi:10.1002/ca.23015

8. Sennert M, Fawzy M, Wirmer J, Graumann C, Hadidi AT. Y-V meatoplasty: a simple novel technique to correct meatal stenosis. J Sex Med. 2025:qdaf236. doi:10.1093/jsxmed/qdaf236

9. Motiwala ZY, Misra S, Desai A, et al. Postoperative urogynecologic complications after gender-affirming surgery: a narrative review. Int Urogynecol J. 2026;37(4):805–822. doi:10.1007/s00192-025-06405-6

10. Fakin RM, Giovanoli P. A single-center study comparison of two different male-to-female penile skin inversion vaginoplasty techniques and their 3.5-year outcomes. J Sex Med. 2021;18(2):391–399. doi:10.1016/j.jsxm.2020.09.014

11. Levy JA, Edwards DC, Cutruzzula-Dreher P, et al. Male-to-female gender reassignment surgery: an institutional analysis of outcomes, short-term complications, and risk factors for 240 patients undergoing penile-inversion vaginoplasty. Urology. 2019;131:228–233. doi:10.1016/j.urology.2019.03.043

12. Mañero I, Arno AI, Herrero R, Labanca T. Cosmetic revision surgeries after transfeminine vaginoplasty. Aesthet Plast Surg. 2023;47(1):430–441. doi:10.1007/s00266-022-03029-9

13. Raigosa M, Avvedimento S, Descarrega J, et al. Refinement procedures for clitorolabiaplasty in male-to-female gender-affirmation surgery: more than an aesthetic procedure. J Sex Med. 2020;17(12):2508–2517. doi:10.1016/j.jsxm.2020.08.006

14. Mann RA, Kasabwala K, Kim N, Pariser JJ. The management of complications of feminizing gender affirming genital surgery. Urology. 2021;152:67–73. doi:10.1016/j.urology.2021.01.031

15. Dy GW, Salibian AA, Blasdel G, Zhao LC, Bluebond-Langner R. External genital revisions after gender-affirming penile inversion vaginoplasty: surgical assessment, techniques, and outcomes. Plast Reconstr Surg. 2022;149(6):1429–1438. doi:10.1097/PRS.0000000000009165

16. Sarin I, Narain TA, Panwar VK, et al. Deciphering the enigma of female urethral strictures: a systematic review and meta-analysis of management modalities. Neurourol Urodyn. 2021;40(1):65–79. doi:10.1002/nau.24584

17. Dothan D, Noyman Y, Perez D, et al. Surgical treatment of meatal stenosis: lessons learned from the pediatric urology practice. Urology. 2023;171:201–204. doi:10.1016/j.urology.2022.08.006

18. Meeks JJ, Barbagli G, Mehdiratta N, Granieri MA, Gonzalez CM. Distal urethroplasty for isolated fossa navicularis and meatal strictures. BJU Int. 2012;109(4):616–619. doi:10.1111/j.1464-410X.2011.10248.x

19. Fiala R, Vrtal R, Zenisek J, Grimes S. Ventral prepucial flap meatoplasty in the treatment of distal urethral male strictures. Eur Urol. 2003;43(6):686–688. doi:10.1016/s0302-2838(03)00186-6

20. Romman A, Takacs L, Gilleran J, Zimmern P. Vestibular flap urethroplasty in women with recurrent distal intramural urethral pathology. Neurourol Urodyn. 2015;34(3):213–218. doi:10.1002/nau.22552

21. Higuchi M, Horiguchi A, Ashiya M, et al. Vaginal flap urethroplasty and dorsal onlay buccal mucosal graft urethroplasty for female urethral stricture: a single-center experience. Int J Urol. 2026;33(5):e70477. doi:10.1111/iju.70477

22. Zumstein V, Dahlem R, Maurer V, et al. Single-stage buccal mucosal graft urethroplasty for meatal stenoses and fossa navicularis strictures: a monocentric outcome analysis and literature review on alternative treatment options. World J Urol. 2020;38(10):2609–2620. doi:10.1007/s00345-019-03035-8

23. Romero-Maroto J, Verdú-Verdú L, Gómez-Pérez L, et al. Lateral-based anterior vaginal wall flap in the treatment of female urethral stricture: efficacy and safety. Eur Urol. 2018;73(1):123–128. doi:10.1016/j.eururo.2016.09.029

24. Morris MP, Wang CW, Lane M, Morrison SD, Kuzon WM. Common revisions after penile inversion vaginoplasty: techniques and clinical outcomes. Plast Reconstr Surg. 2022;149(6):1198e–1201e. doi:10.1097/PRS.0000000000009159

25. Stewart L, McCammon K, Metro M, Virasoro R. SIU/ICUD Consultation on Urethral Strictures: anterior urethra — lichen sclerosus. Urology. 2014;83(3 Suppl):S27–S30. doi:10.1016/j.urology.2013.09.013

26. Faiena I, Koprowski C, Tunuguntla H. Female urethral reconstruction. J Urol. 2016;195(3):557–567. doi:10.1016/j.juro.2015.07.124